Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Mar 2026 and May 2026.
- Largest single sale: $5.0M (144,180 shares) of Teva Pharmaceutical Industries Ltd on May 1, 2026. Filing
- Last sale before this period: May 8, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd (TEVA) | Executive Vice President, International Markets Commercial | Feb 12, 2018 | May 4, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- May 1, 2026, Teva Pharmaceutical Industries Ltd: sold 144,180 shares for $5.0M, no plan disclosed. 1 filing: 1
- Mar 17, 2026, Teva Pharmaceutical Industries Ltd: sold 62,102 shares for $1.9M, no plan disclosed. 1 filing: 1
- Mar 5, 2026, Teva Pharmaceutical Industries Ltd: 15,723 shares vested. 1 filing: 1
- Mar 4, 2026, Teva Pharmaceutical Industries Ltd: 52,113 shares vested. 1 filing: 1
- Mar 3, 2026, Teva Pharmaceutical Industries Ltd: 166,378 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.